12 Results for "

HCV genotypes 5a

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "HCV genotypes 5a" in MCE Product Catalog:

11
11 Cited Publications
Cat. No.: HY-15789
CAS No.: 1370468-36-2
Purity:  99.97%
Synonyms: MK-8742
Target:  

HCV

Research Areas:  

Infection

Elbasvir (MK-8742) is a hepatitis C virus nonstructural protein 5A (HCV NS5A) inhibitor with EC50s of 4, 3 and 3 nM against genotype 1a, 1b, and 2a, respectively.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-12530
CAS No.: 1377049-84-7
Purity:  99.57%
Synonyms: GS-5816
Target:  

HCV SARS-CoV

Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-147358
CAS No.: 1959593-63-5
Purity:  98.09%
Synonyms: Emitasvir diphosphate; DAG-181 diphosphate
Target:  

HCV

Research Areas:  

Infection

Yimitasvir diphosphate (Emitasvir diphosphate; DAG-181 diphosphate) is an orally active inhibitor of hepatitis C virus (HCV) nonstructural protein 5A (NS5A). Yimitasvir diphosphate is applicable to research related to HCV infection .
loading...
    loading...
Cat. No.: HY-12530R
CAS No.: 1377049-84-7
Synonyms: GS-5816 (Standard)
Velpatasvir (Standard) is the analytical standard of Velpatasvir. This product is intended for research and analytical applications. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-147358A
CAS No.: 1959593-23-7
Synonyms: Emitasvir; DAG-181
Target:  

HCV

Research Areas:  

Infection

Yimitasvir (Emitasvir; DAG-181) is an orally active inhibitor of hepatitis C virus (HCV) nonstructural protein 5A (NS5A). Yimitasvir is applicable to research related to HCV infection .
loading...
    loading...
Cat. No.: HY-15789R
CAS No.: 1370468-36-2
Synonyms: MK-8742 (Standard)
Target:  

Reference Standards HCV

Research Areas:  

Infection

Elbasvir (Standard) is the analytical standard of Elbasvir. This product is intended for research and analytical applications. Elbasvir (MK-8742) is a hepatitis C virus nonstructural protein 5A (HCV NS5A) inhibitor with EC50s of 4, 3 and 3 nM against genotype 1a, 1b, and 2a, respectively.
loading...
    loading...
Cat. No.: HY-12530S1
Synonyms: GS-5816-d33
Velpatasvir-d3 (GS-5816-d3) is deuterium labeled Velpatasvir. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-131905S
CAS No.: 1606150-08-6
BMS-986144 is an orally active inhibitor of HCV NS3/4A protease. BMS-986144 binds to the active site of HCV NS3/4A protease and induces conformational changes in the protease. BMS-986144 reduces time-dependent CYP3A4 inhibition, exhibits hepatic microsomal metabolic stability, and undergoes oxidation of the macrocyclic linker chain. BMS-986144 can be used in studies related to hepatitis C virus infection .
loading...
    loading...
Cat. No.: HY-125182
CAS No.: 2649904-85-6
Target:  

Cyclophilin HCV

Research Areas:  

Infection

SMCypI C31 is a non-peptidic cyclophilin inhibitor with potent peptidyl-prolyl cis/trans isomerases (PPIase) inhibitory activity (IC50 of 0.1 µM). SMCypI C31 shows pangenotype anti-HCV activity with EC50s ranging from 1.20 to 7.76 μM for genotype 1a, 1b, 2a, 3a, and 5a HCV subgenomic replicons (HCV-SGRs) and chimeric genotype 2a/4a HCV-SGRs. SMCypI C31 disrupts the cyclophilin A-NS5A interaction .
loading...
    loading...
Cat. No.: HY-W749691
Synonyms: (S)-GS-5816-13C,d3
(S)-Velpatasvir- 13C,d3 ((S)-GS-5816- 13C,d3) is 13C labeled Velpatasvir. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-12530S3
Synonyms: GS-5816-13C,d3
Velpatasvir- 13C,d3 (GS-5816- 13C,d3) is 13C and deuterium labeled Velpatasvir. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
Cat. No.: HY-184880
CAS No.: 1410114-25-8
Target:  

HCV Protease HCV

Research Areas:  

Infection

BMS-986144 non-deuterated is the non-tritium form of BMS-986144 (HY-131905S). BMS-986144 non-deuterated is an orally active inhibitor of HCV NS3/4A protease. BMS-986144 non-deuterated binds to the active site of HCV NS3/4A protease and induces conformational changes in the protease. BMS-986144 non-deuterated reduces time-dependent CYP3A4 inhibition, exhibits hepatic microsomal metabolic stability, and undergoes oxidation of the macrocyclic linker chain. BMS-986144 non-deuterated can be used in studies related to hepatitis C virus infection .
loading...
    loading...
  • 1